Updates on the Treatment Approach for MCL
The CAR-HEMATOTOX Score Identifies Patients at High Risk for Hematological Toxicity, Infections, and Poor Clinical Outcomes Following Brexucabtagene Autoleucel in R/R MCL
By
ASH 2022 Conference Coverage
FEATURING
Kai Rejeski
By
ASH 2022 Conference Coverage
FEATURING
Kai Rejeski
Login to view comments.
Click here to Login
Updates on the Treatment Approach for MCL